Merck Validates BTK Inhibitors with US$2.7 B ArQule Buy
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 12 (Table of Contents)
Published: 12 Dec-2019
DOI: 10.3833/pdr.v2019.i12.2478 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Continuing its diversification strategy, Merck & Co...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS